FIELD: medicine.
SUBSTANCE: invention relates to new peptide and pharmaceutical composition for the treatment of eye disease, which includes peptide as an active pharmaceutical ingredient. When new peptide of the present invention is injected into the eyes, it increases the number of secreted tears and restores the damaged cornea.
EFFECT: invention can be effectively used as a therapeutic agent for the treatment of eye disease.
17 cl, 173 dwg, 18 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDES AND PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE DISEASES | 2019 |
|
RU2819399C2 |
| MODIFIED ANALOGUES OF GIP PEPTIDE | 2019 |
|
RU2817673C2 |
| HIGH-PENETRATION PRODRUG COMPOSITIONS BASED ON PEPTIDES AND PEPTIDE-RELATED COMPOUNDS | 2010 |
|
RU2767051C2 |
| USE OF OPTIONS OF NATRIURETIC PEPTIDE OF TYPE C FOR TREATMENT OF OSTEOARTHRITIS | 2016 |
|
RU2759679C2 |
| ANTIMICROBIAL PEPTIDE | 2014 |
|
RU2695455C2 |
| NOVEL OXYNTOMODULIN DERIVATIVES AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM FOR TREATING OBESITY | 2012 |
|
RU2739209C2 |
| LIQUID PHARMACEUTICAL FORMULATIONS OF PTH CONJUGATES | 2020 |
|
RU2817015C2 |
| PEPTIDES CAPABLE OF REACTIVATING P53 MUTANTS | 2014 |
|
RU2721423C2 |
| SYSTEM FOR PRESENTATION OF PEPTIDES ON CELL SURFACE | 2016 |
|
RU2739593C2 |
| PEPTIDE, OBTAINED FROM MPHOSPH1, AND INCLUDING ITS VACCINE | 2016 |
|
RU2731099C2 |
